調查批次:CHT2015-04 | 檢體寄出日期:2015-04-27 | 報告回收截止日期:2015-05-04 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
2 |
5 |
2.28 |
-0.58 |
-20.3 |
-2.5 |
-0.7 |
-84 |
1.18 |
-0.04 |
-3.3 |
-0.4 |
-0.1 |
-13 |
RH07b | RH07 | 7 |
2 |
3 |
3.68 |
0.82 |
28.7 |
3.6 |
1.5 |
119 |
1.21 |
-0.01 |
-0.8 |
-0.1 |
0.2 |
-3 |
RH14 | RH14 | 4 |
2 |
3 |
3.06 |
0.20 |
7.0 |
0.9 |
0.5 |
29 |
1.03 |
-0.19 |
-15.6 |
-1.9 |
-1.3 |
-63 |
RH15 | RH15 | 7 |
2 |
5 |
2.20 |
-0.66 |
-23.1 |
-2.9 |
-0.8 |
-96 |
1.18 |
-0.04 |
-3.3 |
-0.4 |
-0.1 |
-13 |
CL009 | CL009 | 7 |
2 |
5 |
2.14 |
-0.72 |
-25.2 |
-3.1 |
-0.9 |
-104 |
1.13 |
-0.09 |
-7.4 |
-0.9 |
-0.5 |
-30 |
CL010 | CL010 | 3 |
2 |
5 |
2.47 |
-0.39 |
-13.6 |
-1.7 |
-0.4 |
-57 |
1.37 |
0.15 |
12.3 |
1.5 |
1.5 |
50 |
CL012 | CL012 | 7 |
2 |
3 |
3.10 |
0.24 |
8.4 |
1.0 |
0.6 |
35 |
1.30 |
0.08 |
6.6 |
0.8 |
0.9 |
27 |
CL013 | CL013 | 3 |
2 |
5 |
2.21 |
-0.65 |
-22.7 |
-2.8 |
-0.8 |
-94 |
1.07 |
-0.15 |
-12.3 |
-1.5 |
-1.0 |
-50 |
CL015 | CL015 | 7 |
2 |
3 |
3.24 |
0.38 |
13.3 |
1.7 |
0.8 |
55 |
1.27 |
0.05 |
4.1 |
0.5 |
0.7 |
17 |
Median of RIA Group |
2.47 |
1.18 |
||||||||||||||
Range of RIA Group |
2.14 - 3.68 |
1.03 - 1.37 |
||||||||||||||
Robust mean of RIA Group |
2.71 ( n = 9 ) |
1.19 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
0.64 |
0.12 |
||||||||||||||
CV of RIA Group |
23.6% |
10.1% |
||||||||||||||
Median of European RIA Labs |
2.46 ( n = 103 ) |
1.20 ( n = 101 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
2.24 - 2.84 |
1.13 - 1.32 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 2 |
4 |
9 |
3.12 |
0.26 |
9.1 |
1.1 |
1.3 |
38 |
1.39 |
0.17 |
13.9 |
1.7 |
1.2 |
57 |
RH02c | RH02 | 7 |
4 |
1 |
2.07 |
-0.79 |
-27.6 |
-3.4 |
-1.2 |
-114 |
1.01 |
-0.21 |
-17.2 |
-2.1 |
-0.5 |
-70 |
RH06 | RH06 | 2 |
4 |
9 |
2.86 |
0.00 |
0.0 |
0.0 |
0.6 |
0 |
1.35 |
0.13 |
10.7 |
1.3 |
1.0 |
43 |
RH07a | RH07 | 2 |
4 |
2 |
2.68 |
-0.18 |
-6.3 |
-0.8 |
0.2 |
-26 |
0.97 |
-0.25 |
-20.5 |
-2.5 |
-0.7 |
-83 |
RH12 | RH12 | 2 |
4 |
2 |
2.40 |
-0.46 |
-16.1 |
-2.0 |
-0.5 |
-67 |
0.96 |
-0.26 |
-21.3 |
-2.6 |
-0.7 |
-87 |
RH19 | RH19 | 5 |
4 |
2 |
2.39 |
-0.47 |
-16.4 |
-2.0 |
-0.5 |
-68 |
0.93 |
-0.29 |
-23.8 |
-2.9 |
-0.9 |
-97 |
RH20 | RH20 | 2 |
4 |
7 |
2.71 |
-0.15 |
-5.2 |
-0.7 |
0.3 |
-22 |
1.10 |
-0.12 |
-9.8 |
-1.2 |
-0.1 |
-40 |
CL005 | CL005 | 3 |
4 |
9 |
2.99 |
0.13 |
4.5 |
0.6 |
1.0 |
19 |
1.43 |
0.21 |
17.2 |
2.1 |
1.4 |
70 |
CL006a | CL006 | 3 |
4 |
7 |
2.47 |
-0.39 |
-13.6 |
-1.7 |
-0.3 |
-57 |
1.15 |
-0.07 |
-5.7 |
-0.7 |
0.1 |
-23 |
CL008 | CL008 | 4 |
4 |
2 |
2.38 |
-0.48 |
-16.8 |
-2.1 |
-0.5 |
-70 |
0.92 |
-0.30 |
-24.6 |
-3.0 |
-0.9 |
-100 |
CL011 | CL011 | 0 |
4 |
13 |
3.01 |
0.15 |
5.2 |
0.7 |
1.0 |
22 |
1.27 |
0.05 |
4.1 |
0.5 |
0.7 |
17 |
CL014b | CL014 | 7 |
4 |
1 |
1.97 |
-0.89 |
-31.1 |
-3.9 |
-1.5 |
-129 |
0.98 |
-0.24 |
-19.7 |
-2.4 |
-0.6 |
-80 |
Median of CLIA Group |
2.58 |
1.06 |
||||||||||||||
Range of CLIA Group |
1.97 - 3.12 |
0.92 - 1.43 |
||||||||||||||
Robust mean of CLIA Group |
2.59 ( n = 12 ) |
1.12 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
0.42 |
0.22 |
||||||||||||||
CV of CLIA Group |
16.2% |
19.6% |
||||||||||||||
Median of European CLIA Labs |
2.93 ( n = 1026 ) |
1.22 ( n = 1042 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
2.22 - 3.14 |
1.01 - 1.31 |
||||||||||||||
Median of All Labs |
2.47 |
1.15 |
||||||||||||||
Range of All Labs |
1.97 - 3.68 |
0.92 - 1.43 |
||||||||||||||
Robust mean of All Labs |
2.62 ( n = 21 ) |
1.15 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.48 |
0.18 |
||||||||||||||
CV of All Labs |
18.3% |
15.7%
|
||||||||||||||
Median of All European Labs ( Xa ) |
2.86 |
1.22 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
2.24 - 3.14 |
1.01 - 1.32 |
||||||||||||||
Mean of All European Labs |
2.74 ( n = 1197 ) |
1.18 ( n = 1199 ) |
||||||||||||||
SD of All European Labs |
0.436 |
0.14 |
||||||||||||||
CV of All European Labs |
16.0% |
11.8% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.229 |
0.10 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2015-05-06